Mankind Pharma Ltd (MANKIND) — Net Asset Momentum
Mankind Pharma Ltd (MANKIND) recorded a net asset momentum of 13.7% as of March 2026, with net assets of Rs165.61 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Mankind Pharma Ltd net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Mankind Pharma Ltd Net Asset Momentum (2019–2026)
This chart tracks Mankind Pharma Ltd's year-over-year net asset growth across 8 annual reporting periods from 2019 to 2026. The most recent momentum reading is +13.7%, with net assets of Rs165.61 Billion INR as of March 2026. For live market cap and overall valuation, see market value of Mankind Pharma Ltd.
Annual Net Asset History for Mankind Pharma Ltd (2019–2026)
The table below shows the complete annual net asset history for Mankind Pharma Ltd from 2019 to 2026, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Mankind Pharma Ltd (MANKIND) tangible equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | Rs165.61 Billion | Rs280.80 Billion | Rs115.18 Billion | ▲ +13.7% |
| 2025 | Rs145.68 Billion | Rs277.60 Billion | Rs131.91 Billion | ▲ +52.1% |
| 2024 | Rs95.76 Billion | Rs119.63 Billion | Rs23.87 Billion | ▲ +25.2% |
| 2023 | Rs76.49 Billion | Rs97.15 Billion | Rs20.67 Billion | ▲ +21.1% |
| 2022 | Rs63.16 Billion | Rs91.48 Billion | Rs28.31 Billion | ▲ +29.9% |
| 2021 | Rs48.63 Billion | Rs63.73 Billion | Rs15.10 Billion | ▲ +32.4% |
| 2020 | Rs36.72 Billion | Rs50.73 Billion | Rs14.02 Billion | ▲ +23.1% |
| 2019 | Rs29.82 Billion | Rs41.12 Billion | Rs11.31 Billion | — |